Boston Trust Walden Corp Agilent Technologies, Inc. Transaction History

Boston Trust Walden Corp

$13.5 Billion
Q1 2025

A detailed history of Boston Trust Walden Corp transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Boston Trust Walden Corp holds 371,673 shares of A stock, worth $41.4 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

371,673

Previous 385,132 3.49%

Holding current value

$41.4 Million

Previous $51.7 Million 15.97%

% of portfolio

0.32%

Previous 0.37%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 21, 2025	SELL	$116.69 - $152.6 $1.57 Million - $2.05 Million	-13,459 Reduced 3.49%	371,673 $43.5 Million
Q4 2024 Jan 24, 2025	SELL	$125.69 - $146.56 $2.15 Million - $2.51 Million	-17,122 Reduced 4.26%	385,132 $51.7 Million
Q3 2024 Oct 24, 2024	SELL	$125.42 - $148.48 $721,541 - $854,205	-5,753 Reduced 1.41%	402,254 $59.7 Million
Q2 2024 Jul 19, 2024	SELL	$129.63 - $154.64 $10,370 - $12,371	-80 Reduced 0.02%	408,007 $52.9 Million
Q1 2024 Apr 22, 2024	BUY	$128.12 - $149.31 $483,268 - $563,197	3,772 Added 0.93%	408,087 $59.4 Million
Q4 2023 Jan 24, 2024	SELL	$101.17 - $139.82 $3.13 Million - $4.32 Million	-30,903 Reduced 7.1%	404,315 $56.2 Million
Q3 2023 Oct 18, 2023	BUY	$109.73 - $128.47 $118,727 - $139,004	1,082 Added 0.25%	435,218 $48.7 Million
Q2 2023 Jul 24, 2023	BUY	$114.69 - $141.28 $2.12 Million - $2.61 Million	18,468 Added 4.44%	434,136 $52.2 Million
Q1 2023 Apr 19, 2023	BUY	$131.13 - $159.06 $1.26 Million - $1.52 Million	9,579 Added 2.36%	415,668 $57.5 Million
Q4 2022 Jan 20, 2023	BUY	$125.64 - $157.68 $5.39 Million - $6.77 Million	42,933 Added 11.82%	406,089 $0
Q3 2022 Oct 19, 2022	BUY	$115.11 - $142.29 $5.34 Million - $6.6 Million	46,393 Added 14.65%	363,156 $44.1 Million
Q2 2022 Jul 22, 2022	BUY	$112.71 - $135.93 $28.4 Million - $34.3 Million	251,971 Added 388.89%	316,763 $37.6 Million
Q1 2022 Apr 20, 2022	BUY	$126.0 - $156.48 $108,360 - $134,572	860 Added 1.35%	64,792 $8.57 Million
Q4 2021 Jan 21, 2022	SELL	$147.95 - $164.3 $617,691 - $685,952	-4,175 Reduced 6.13%	63,932 $10.2 Million
Q3 2021 Oct 25, 2021	SELL	$147.58 - $179.28 $64,935 - $78,883	-440 Reduced 0.64%	68,107 $10.7 Million
Q2 2021 Jul 22, 2021	SELL	$127.69 - $148.81 $6,767 - $7,886	-53 Reduced 0.08%	68,547 $10.1 Million
Q1 2021 Apr 21, 2021	SELL	$114.99 - $130.12 $484,337 - $548,065	-4,212 Reduced 5.78%	68,600 $8.72 Million
Q4 2020 Jan 15, 2021	SELL	$100.01 - $119.3 $47,004 - $56,071	-470 Reduced 0.64%	72,812 $8.63 Million
Q3 2020 Oct 14, 2020	SELL	$88.11 - $103.42 $127,759 - $149,959	-1,450 Reduced 1.94%	73,282 $7.4 Million
Q2 2020 Jul 23, 2020	BUY	$68.92 - $91.14 $187,807 - $248,356	2,725 Added 3.78%	74,732 $6.6 Million
Q1 2020 Apr 21, 2020	BUY	$63.37 - $90.13 $101,392 - $144,208	1,600 Added 2.27%	72,007 $5.16 Million
Q4 2019 Jan 10, 2020	SELL	$72.49 - $85.45 $1.09 Million - $1.28 Million	-15,020 Reduced 17.58%	70,407 $6.01 Million
Q3 2019 Oct 21, 2019	BUY	$65.59 - $78.07 $318,767 - $379,420	4,860 Added 6.03%	85,427 $6.55 Million
Q2 2019 Jul 25, 2019	BUY	$66.89 - $81.94 $1.09 Million - $1.34 Million	16,325 Added 25.41%	80,567 $6.02 Million
Q1 2019 Apr 16, 2019	BUY	$63.27 - $82.0 $378,038 - $489,950	5,975 Added 10.25%	64,242 $5.16 Million
Q4 2018 Jan 17, 2019	BUY	$61.13 - $74.67 $640,336 - $782,168	10,475 Added 21.92%	58,267 $3.93 Million
Q3 2018 Oct 23, 2018	BUY	$61.25 - $71.13 $4,593 - $5,334	75 Added 0.16%	47,792 $3.37 Million
Q2 2018 Jul 25, 2018	BUY	$61.14 - $69.55 $2.69 Million - $3.06 Million	44,005 Added 1185.48%	47,717 $2.95 Million
Q1 2018 Apr 13, 2018	SELL	$65.05 - $74.82 $6,505 - $7,481	-100 Reduced 2.62%	3,712 $248,000
Q3 2017 Oct 13, 2017	BUY	$58.57 - $66.17 $223,268 - $252,240	3,812	3,812 $245,000

Others Institutions Holding A

# of Institutions

1,155

Shares Held

256M

Call Options Held

1.09M

Put Options Held

913K

View Full List

About AGILENT TECHNOLOGIES, INC.

Ticker A
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 296,040,992
Market Cap $32.9B
Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...

More about A

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Account

Boston Trust Walden Corp Agilent Technologies, Inc. Transaction History